Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Optical Disorders Drugs 78
Oncology Drugs 76
Optical 75
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Biotechnology 28
Genomics 28
Clinical Trials 27
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 21
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Diagnostics 8
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Therapeutic Area 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

671 Results (Page 2 of 34)
- Relevance
  Sort by

Gout Therapeutics - Global Strategic Business Report

 Report
April 2025
93 Pages
Global

From

€5308EUR$5,600USD£4,434GBP

Aflibercept (Eylea) Biosimilars Pipeline Review

 Report
April 2025
Global

From

€300EUR$339USD£259GBP

Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type, Route of Administration, Indication - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3360EUR$3,545USD£2,807GBP

€3733EUR$3,939USD£3,119GBP

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025

 Report
April 2025
550 Pages
Global

From

€3787EUR$3,995USD£3,163GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
April 2025
750 Pages
Global

From

€3787EUR$3,995USD£3,163GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Anterior Uveitis Treatment Market by Treatment Type, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3360EUR$3,545USD£2,807GBP

€3733EUR$3,939USD£3,119GBP

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
325 Pages
Global

From

€4549EUR$4,799USD£3,800GBP

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

 Report
April 2025
300 Pages
Global

From

€3787EUR$3,995USD£3,163GBP

Anterior Uveitis Treatment Market 2024-2028

 Report
July 2024
133 Pages
Global

From

€2370EUR$2,500USD£1,980GBP

Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4256EUR$4,490USD£3,555GBP

Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
January 2022
242 Pages
Global

From

€4549EUR$4,799USD£3,800GBP

Gout Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Corticosteroids, Colchicine), By Disease Condition (Acute, Chronic), By Distribution Channel, By Region, And Segment Forecasts, 2023-2030

 Report
June 2023
100 Pages
Global

From

€5640EUR$5,950USD£4,711GBP

Companion Diagnostics Development Services Market: Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
March 2022
405 Pages
Global

From

€4549EUR$4,799USD£3,800GBP

Gout Therapeutics Market by Drug Class, Treatment, Route of Administration, Application - Global Forecast 2025-2030

 Report
October 2024
196 Pages
Global

From

€3360EUR$3,545USD£2,807GBP

€3733EUR$3,939USD£3,119GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4256EUR$4,490USD£3,555GBP

Skin Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4502EUR$4,750USD£3,761GBP

Microneedle Flu Vaccine Market

 Report
January 2024
200 Pages
Global

From

€3933EUR$4,150USD£3,286GBP

Natural Killer Cell Therapeutics Market by Therapeutics, Approaches, Application, End User - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3360EUR$3,545USD£2,807GBP

€3733EUR$3,939USD£3,119GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
182 Pages
Global

From

€4265EUR$4,500USD£3,563GBP

Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

 Report
October 2023
161 Pages
Global

From

€2370EUR$2,500USD£1,980GBP

671 Results (Page 2 of 34)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.